These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7634303)

  • 1. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB; Smith RD
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC; Timmermans PB
    Blood Press Suppl; 1996; 3():11-4. PubMed ID: 8973760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B; Brunner HR
    Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future role of losartan.
    Hansson L
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antagonists of angiotensin II receptor].
    Karasek D; Adamski M; Grzeszczak W
    Postepy Hig Med Dosw; 1996; 50(1):21-32. PubMed ID: 8778711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan in patients with renal insufficiency.
    de Zeeuw D; Gansevoort RT; de Jong PE
    Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M; Klein W; Huber K; Pachinger O
    Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.